Melissa Byrne

Melissa Byrne is a Principal at Brandon Capital Partners in Melbourne, Victoria, Australia, where she focuses on life sciences investments. Joining the venture capital firm in 2018, she leverages over 15 years of experience as a cardiovascular physiologist bridging academic research and commercial development. Previously, Byrne held an academic position at the Baker Heart Institute, leading pre-clinical research and first-in-man clinical trials, and completed a Guidant Industry Fellowship at Johns Hopkins Medicine. She currently serves as a Director for Pathios Therapeutics and Perx Health, acts as an Alternate Director for George Medicines, and is a named inventor on four United States patent filings. Byrne earned a PhD in Cardiovascular Physiology from Monash University and a Bachelor of Science from The University of Melbourne. Her ongoing focus remains on translating early-stage medical research into commercialized cardiovascular devices and clinical therapeutics.